Clinical Trials Logo

Pregnancy clinical trials

View clinical trials related to Pregnancy.

Filter by:

NCT ID: NCT02142452 Completed - Pregnancy Clinical Trials

Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain

Start date: March 2014
Phase: N/A
Study type: Interventional

The investigators will test the efficacy of a tailored behavioral lifestyle modification program to support cardiovascular health in postpartum women with excessive gestational weight gain. This program will include a mobile health texting component postpartum to support changes in nutrition and physical activity. The investigators will randomize women into either the control arm (usual care) or the intervention (usual care + mobile health program postpartum). The women will be recruited during their 3rd trimester once they have been identified as gaining too much weight according to the 2009 IOM guidelines during pregnancy.

NCT ID: NCT02140879 Withdrawn - Pregnancy Clinical Trials

LA Moms and Babies Study (LAMBS) for Nutrition and Growth

LAMBS
Start date: April 2014
Phase: N/A
Study type: Interventional

This research study will examine how diet during pregnancy can benefit pregnancy and pregnancy outcome, such as your baby's weight. More specifically, the investigators will study the effects of two different food oils/fats that are commonly consumed to determine if one is more effective in limiting maternal inflammation during pregnancy. You are being asked to take part in this study because it will help us update and make the best dietary recommendations for pregnant women and women of child bearing ages.

NCT ID: NCT02137200 Terminated - Pregnancy Clinical Trials

Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial

OMSS
Start date: May 24, 2014
Phase: N/A
Study type: Interventional

The investigators propose a large, multicenter, randomized clinical trial of immediate versus delayed pushing for nulliparous women in labor at term reaching complete cervical dilation. The central hypothesis is that immediate pushing in the second stage of labor increases spontaneous vaginal delivery, shortens duration of the second stage, and reduces adverse neonatal and maternal outcomes in nulliparous women. They will pursue the following specific aims: 1) Assess the effectiveness of immediate pushing at complete cervical dilation on the rate of spontaneous vaginal delivery in nulliparous women (Primary Aim), 2) Determine the effect of immediate pushing on the rate of neonatal composite morbidity (Secondary Aim #1), and 3) Determine the impact of immediate versus delayed pushing on objective and subjective measures of maternal pelvic floor morbidity (Secondary Aim #2). They estimate that randomizing a total of 3184 women will provide adequate statistical power to detect meaningful differences in the primary and secondary outcomes.

NCT ID: NCT02129465 Recruiting - Pregnancy Clinical Trials

Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy

CMV
Start date: June 2014
Phase: N/A
Study type: Observational

Analysis of several characteristics of blood from pregnant women with CMV infection according to maternal-fetal transmission. These include CMV viral load, cytokine profile in response to in-vitro stimulation with CMV peptides, meticulous analysis of anti CMV antibodies, maternal DNA polymorphism and microarray of gene expression.

NCT ID: NCT02128685 Completed - Pregnancy Clinical Trials

Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage

Start date: March 2016
Phase: Phase 3
Study type: Interventional

The aim of this study is to determine whether the dydrogesterone therapy is associated with reduction in miscarriage in women with first trimester threatened miscarriage. The hypothesis is that the dydrogesterone therapy will significantly reduce the risk of miscarriage in women with threatened miscarriage.

NCT ID: NCT02125370 Completed - Pregnancy Clinical Trials

Experiences of Pregnant Women Who Use NRT in Pregnancy as Part of a Quit Attempt

Start date: April 2014
Phase: N/A
Study type: Observational

This study is largely a qualitative study with a small survey component. The aim of the survey would be to gain a quantitative perspective of how women use NRT after this has been prescribed by stop smoking services (SSS). The aim of the qualitative study would be to enhance knowledge of pregnant smoker's views and attitudes about their experiences of using NRT and in particular to understand why pregnant women who start using NRT often discontinue this early or do not use the medication as it is prescribed. This information is important for a number of reasons; firstly it will help health professionals and researchers gain an in depth understanding about how women experience using NRT, which may be used to help devise strategies for encouraging better adherence and which could be used in future clinical trials to gain a clearer understanding as to whether or not NRT is effective in pregnancy.

NCT ID: NCT02125149 Active, not recruiting - Pregnancy Clinical Trials

The Expecting Study

Start date: September 2, 2014
Phase: N/A
Study type: Interventional

The purpose of the study is to determine how a mother's health and physical activity may influence her child's growth and development.

NCT ID: NCT02124642 Completed - Pregnancy Clinical Trials

Folic Acid Supplementation in Pregnant Women: Dose Response

FAPREG
Start date: May 2014
Phase: N/A
Study type: Interventional

The proposed study is a double-blind randomized controlled trial in healthy pregnant women (BMI 18.5 - 29.9 kg/m2, age 18 - 40 yr) receiving prenatal care at Athens Regional Midwifery clinic (ARMC). The primary goal of the proposed study is to determine relative changes in blood folate and DNA methylation levels in response to 2 different supplemental doses of folic acid one of which will provide the Institute of Medicine's recommended folate intake for pregnant women and the second will provide a higher dose as routinely taken by pregnant women in over-the-counter prenatal supplements. The specific aims of the study are: 1. to compare maternal serum and red blood cell (RBC) folate levels and % change in women taking either 400 or 800 mcg/day of supplemental folic acid from the first prenatal visit (< 10 weeks) through delivery; 2. to compare the infant's cord blood folate levels in response to different maternal folic acid intakes (400 mcg/d vs 800 mcg/d); 3. to determine relative differences in the levels of oxidized folic acid in maternal and infant blood in response to 400 or 800 mcg/d folic acid dose, and 4. to determine genome wide and gene specific DNA methylation response in pregnant women receiving prenatal supplements containing either 400 or 800 mcg folic acid per day

NCT ID: NCT02124291 Terminated - Pregnancy Clinical Trials

Effect of Assisted Hatching on Vitrified Embryo Transfer Clinical Outcome

VitHatSZMC
Start date: June 2014
Phase: N/A
Study type: Interventional

The objective of study is to assess the possible impact of assisted hatching on the implantation, pregnancy rate and delivery rate after transfer of vitrified-warmed human embryos.

NCT ID: NCT02122419 Completed - Pregnancy Clinical Trials

The Effect of Patient Position on Postdural Puncture Headache

Start date: April 2014
Phase: N/A
Study type: Observational

We aimed to investigate the association between the position in which spinal anesthesia was performed and postdural puncture headache occurrence.